ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
129.284,62
-0,03%
S&P 500
5.649,17
0,32%
US Dollar vs BRL
5,413
-0,65%
Bitcoin
63.769,62
-1,66%
Brent Oil
83,10
-1,47%
Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Allos Therapeutics, Inc. (MM) (ALTH)

  7. Allos Therapeutics, Inc. (MM) (ALTH) Notícias

ALTH

Allos Therapeutics, Inc. (MM) (ALTH)

Allos Therapeutics, Inc. (MM)
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:ALTH
DataHoraFonteTítuloCódigoCompanhia
30/01/201211:30Business WireAllos Therapeutics Requests Re-Examination of CHMP Opinion on FOLOTYN® in PTCL at the European Medicines AgencyNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
30/01/201211:00Business WireAllos Therapeutics Announces Interim Results from Phase 1 Combination Study of FOLOTYN® & Bexarotene Demonstrate Activity in...NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
23/01/201210:00ZacksEuropean Setback for Allos - Analyst BlogNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
20/01/201210:49Edgar (US Regulatory)Current report filing (8-K)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
20/01/201210:43Business WireAllos Therapeutics Receives Negative Opinion from the CHMP on FOLOTYNNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
12/01/201215:15ZacksAllos Therapeutics Cut to Neutral - Analyst BlogNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
11/01/201211:15ZacksAMAG Q4 Sales Set to Disappoint - Analyst BlogNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
10/01/201211:00Business WireAllos Therapeutics Reports 2011 Financial Highlights and Key Business PrioritiesNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
23/12/201120:00Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
21/12/201111:00Business WireAllos Therapeutics Invites Investors to Listen to Webcast of Presentation at J.P. Morgan Healthcare ConferenceNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
15/12/201119:35Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
15/12/201113:00ZacksAMAG's Feraheme Gets Canada Nod - Analyst BlogNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
25/11/201110:15ZacksAllos Continues to Outperform - Analyst BlogNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
18/11/201111:00ZacksAMAG Hires Financial Advisor - Analyst BlogNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
08/11/201111:30ZacksAllos Narrows Loss - Analyst BlogNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
08/11/201107:15ZacksLoss Shrinks at AMAG, CEO Departs - Analyst BlogNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
04/11/201107:05ZacksCompany News for November 4, 2011 - Corporate SummaryNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
03/11/201109:07Edgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
03/11/201109:00Business WireAllos Therapeutics Reports Third Quarter 2011 Financial ResultsNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
26/10/201112:53Edgar (US Regulatory)Amended Statement of Beneficial Ownership (SC 13D/A)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
25/10/201106:14ZacksZacks #1 Rank Additions for Tuesday - Tale of the TapeNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
24/10/201113:00ZacksAMAG/Allos Deal Called Off - Analyst BlogNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
21/10/201111:27Business WireAllos Therapeutics Announces Termination of Merger Agreement with AMAG PharmaceuticalsNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
14/10/201107:02Edgar (US Regulatory)Filing of certain prospectuses and communications in connection with business combination transactions (425)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
13/10/201120:41Business WireAllos Therapeutics Announces Settlement with Putative Class Action Plaintiffs Regarding Merger with AMAG PharmaceuticalsNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
13/10/201109:16MarketwiredStrong Pipelines From Allos Therapeutics and Dynavax Tech Poised to Pay OffNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
10/10/201109:00Business WireAllos Therapeutics Continues to Work Toward Completion of Merger with AMAG PharmaceuticalsNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
23/09/201116:25Business WireRobbins Geller Rudman & Dowd LLP Files Class Action Suit against Allos Therapeutics, Inc.NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
16/09/201117:13Edgar (US Regulatory)Amended Current report filing (8-K/A)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
15/09/201118:05Edgar (US Regulatory)Proxy Statement - Merger or Acquistion (definitive) (DEFM14A)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
 Apresentando as notícias mais relevantes sobre:NASDAQ:ALTH

Seu Histórico Recente

NASDAQ
NYNY
Empire Resorts
NYSE
LYO
Lyondell
BOV
VRTA11
Fator Verita Fundo Inves...
BIT
P1Z5W5
NLBNPIT1Z5W5 20351221 50...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados